Article ; Online: The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with
Journal of managed care & specialty pharmacy
2021 Volume 28, Issue 2, Page(s) 218–231
Abstract: BACKGROUND: ...
| Abstract | BACKGROUND: |
|---|---|
| MeSH term(s) | Antineoplastic Agents/economics ; Budgets ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Formularies as Topic ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Models, Economic ; Proto-Oncogene Proteins c-ret ; Pyrazoles/economics ; Pyridines/economics ; Pyrimidines/economics ; Thyroid Neoplasms/drug therapy ; Thyroid Neoplasms/genetics ; United States |
| Chemical Substances | Antineoplastic Agents ; Pyrazoles ; Pyridines ; Pyrimidines ; pralsetinib ; Proto-Oncogene Proteins c-ret (EC 2.7.10.1) ; RET protein, human (EC 2.7.10.1) |
| Language | English |
| Publishing date | 2021-11-02 |
| Publishing country | United States |
| Document type | Journal Article |
| ISSN | 2376-1032 |
| ISSN (online) | 2376-1032 |
| DOI | 10.18553/jmcp.2021.21308 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.